Pacira BioSciences, Inc. (PCRX)

Pacira BioSciences Financials Overview

Financials in millions USD. Fiscal year is January - December.

Revenue & Profits

Chart

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jun 30, 2026	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021
Revenue Revenue Growth	746.16	726.41	700.97	674.98	666.82	541.53
Revenue Growth	5.71%	3.63%	3.85%	1.22%	23.14%	26.04%
Gross Profit Gross Profit Growth	591.01	576.66	530.54	490.31	467.53	401.28
Operating Income Operating Income Growth	32.83	33.3	97.57	87.32	70.93	89.92
Net Income Net Income Growth	14.64	7.03	-99.56	41.96	15.91	41.98
Earnings Per Share EPS Growth	0.35	0.16	-2.15	0.89	0.34	0.92
EPS Growth	-	-	-	160.68%	-63.04%	-72.37%

Cash & Debt

Chart

Fiscal Year	Current	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jun 30, 2026	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021
Cash & Investments Cash & Investments Growth	251.03	238.42	484.62	278.58	288.65	656.41
Total Debt Total Debt Growth	412.12	418.2	638.85	586.04	763.39	1,129
Net Cash (Debt) Net Cash Growth	-161.09	-179.78	-154.24	-307.46	-474.74	-472.44
Net Cash Growth	-	-	-	-	-	-
Net Cash Per Share Net Cash Per Share Growth	-3.80	-3.99	-3.34	-5.92	-10.20	-10.35

Cash Flow & CapEx

Chart

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jun 30, 2026	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021
Operating Cash Flow Operating Cash Flow Growth	187.66	151.99	189.39	154.65	145.27	125.72
Capital Expenditures CapEx Growth	-8.15	-15.33	-10.64	-15.16	-30.08	-45.87
Free Cash Flow Free Cash Flow Growth	179.52	136.66	178.75	139.49	115.2	79.85
Free Cash Flow Growth	53.34%	-23.55%	28.15%	21.09%	44.27%	103.54%

Margins

Chart

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jun 30, 2026	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021
Gross Margin	79.21%	79.38%	75.69%	72.64%	70.11%	74.10%
Operating Margin	4.40%	4.58%	13.92%	12.94%	10.64%	16.61%
Pretax Margin	2.37%	2.32%	-9.00%	9.14%	1.99%	10.42%
Profit Margin	1.96%	0.97%	-14.20%	6.22%	2.39%	7.75%
FCF Margin	24.06%	18.81%	25.50%	20.67%	17.28%	14.74%

Valuation

Chart

Fiscal Year	Current	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Sep 20, 2026	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021
PE Ratio	70.19	158.29	-	37.35	111.35	63.85
Forward PE	7.71	7.53	7.10	10.23	11.64	15.43
P/FCF Ratio	5.48	8.15	4.87	11.23	15.38	33.57
PS Ratio	1.32	1.53	1.24	2.32	2.66	4.95

Data Source: S&P Global Market Intelligence Last updated: Aug 4, 2026

Financial data is provided by S&P Global Market Intelligence and updates within hours after each earnings release, which is every three months for this company.

Update frequency:

Quarterly

Last checked:

Sep 18, 2026

Data Sources Report a data error